Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Qi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-5289-4910; OpenAlex author ID A5100340168. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Bacteria and tumor debris induced pancreatic cancer progression via the NF-κB signaling pathway. Co-author DOI 10.1016/j.canlet.2025.217964↗
  2. Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis. Co-author DOI 10.1002/1878-0261.12757↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 2 shared papers, 2020–2025 · strength 0.36
  2. Yonghao Xu · 1 shared paper, 2025 · strength 0.27
  3. Xiao Zhi · 1 shared paper, 2020 · strength 0.09
  4. Jian Zhang · 1 shared paper, 2020 · strength 0.09
  5. Tao Wei · 1 shared paper, 2020 · strength 0.09
  6. Xiang Li · 1 shared paper, 2020 · strength 0.09
  7. Qi Zhang · 1 shared paper, 2020 · strength 0.09
  8. Tao Ma · 1 shared paper, 2020 · strength 0.09
  9. Wei Chen · 1 shared paper, 2020 · strength 0.09
  10. Risheng Que · 1 shared paper, 2020 · strength 0.09
  11. Jiaqi Yang · 1 shared paper, 2020 · strength 0.09
  12. Jin Li · 1 shared paper, 2020 · strength 0.09
  13. Xueli Bai · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.